SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/28/2026

1. SPY
2. CDNS
3. NVDA
4. META
5. FFIV
6. AAPL
7. USO
8. TFII
9. XFLT
10. AMZN

Go back to SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
SCYNEXIS (NASDAQ: SCYX) Delayed: 3.63 +0.06 (1.68%)
Previous Close $3.57    52 Week High $7.29 
Open $3.55    52 Week Low $1.74 
Day High $3.76    P/E N/A 
Day Low $3.53    EPS $0.00 
Volume 27,183